在SARSCOV-2患者中非侵入性通风 (NIV) 诱导的双边皮下肺气:一种罕见的现象
Sunil Routaray1, Chandrakant Prasad1, Vanitha Rajagopalan1
1Department of Neuroanaesthesiology and Critical Care, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Trends in anaesthesia & critical care
|April 15, 2024
概括
一名COVID-19患者在非侵入性通风后出现皮下肺. 本案例报告详细介绍了这种罕见并发症的原因,差异和成功管理.
科学领域:
- 医学 医学 医学 医学 医学
- 肺部病理学 肺部病理学
- 关键的护理关键的护理
背景情况:
- 冠状病毒疾病-2019 (COVID-19) 可能导致呼吸道并发症.
- 非侵入性通风 (NIV) 是COVID-19中缺氧呼吸衰竭的常见治疗方法.
- 皮下肺气是一种罕见但潜在的呼吸辅助并发症.
研究的目的:
- 在接受NIV治疗的COVID-19患者中报告双边皮下肺气的病例.
- 在这个背景下讨论皮下肺的病因和差异诊断.
- 为了突出成功的管理策略对这种并发症.
主要方法:
- 一个COVID-19患者的病例报告.
- 对皮下肺瘤的原因和治疗的文献综述.
- 临床评估和成像.
主要成果:
- 在NIV启动后,患者在部和胸部上部出现了双边皮下肺.
- 考虑了包括巴罗创伤和空气泄漏在内的各种原因.
- 取得了成功的保守管理.
结论:
- 皮下肺是NIV在COVID-19患者的可能并发症.
- 迅速识别和适当管理对于有利的结果至关重要.
- 这一案例强调了在呼吸辅助过程中保持警监测的重要性.
相关概念视频
Mechanical Ventilation II: Invasive Ventilation
131
Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
131
Mechanical Ventilation III: Noninvasive Ventilation
110
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
Noninvasive Positive-Pressure Ventilation...
110
Acute Respiratory Failure-III
184
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
184
Acute Respiratory Failure-V
136
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
136
Acute Respiratory Failure-II
218
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
218


